Johnson & Johnson (JNJ) Inventory Average (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Inventory Average came in at $14.4 billion in Q1 2026, up 14.62% year-on-year from $12.6 billion in Q1 2025, and up 1.54% quarter-over-quarter from $14.2 billion in Q4 2025.

Johnson & Johnson (JNJ) Inventory Average (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Inventory Average across 18 years of filings, most recently posting $14.4 billion for Q1 2026.

  • Inventory Average for Q1 2026 came in at $14.4 billion, up 14.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.4 billion (up 14.62% YoY), and the FY2025 annual result was $13.3 billion, up 12.74% from the prior year.
  • Inventory Average came in at $14.4 billion for Q1 2026 at Johnson & Johnson, up from $14.2 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $14.4 billion in Q1 2026 to a low of $10.4 billion in Q1 2022.
  • The 5-year median for Inventory Average is $11.9 billion (2023), against an average of $12.1 billion.
  • Across the five-year window, Inventory Average slipped 8.35% in 2024 and advanced 14.62% in 2026, its largest moves.
  • Johnson & Johnson's Inventory Average stood at $11.6 billion in 2022, then dropped by 3.17% to $11.2 billion in 2023, then increased by 11.92% to $12.5 billion in 2024, then increased by 13.14% to $14.2 billion in 2025, then gained by 1.54% to $14.4 billion in 2026.
  • The last three Inventory Average figures came in at $14.4 billion (Q1 2026), $14.2 billion (Q4 2025), and $13.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 8.09 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 14.14 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 14.39 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 5.00 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 6.57 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 6.21 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 1.84 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 10.66 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 2.72 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 14.39 Bn
Dec 28, 2025 14.17 Bn
Sep 28, 2025 13.78 Bn
Jun 29, 2025 13.04 Bn
Mar 30, 2025 12.55 Bn
Dec 29, 2024 12.52 Bn
Sep 29, 2024 12.39 Bn
Jun 30, 2024 11.78 Bn
Mar 31, 2024 11.28 Bn
Dec 31, 2023 11.19 Bn
Oct 1, 2023 12.04 Bn
Jul 2, 2023 12.85 Bn
Apr 2, 2023 11.54 Bn
Jan 1, 2023 10.97 Bn
Oct 2, 2022 11.56 Bn
Jul 3, 2022 11.21 Bn
Apr 3, 2022 10.69 Bn
Jan 2, 2022 10.39 Bn
Oct 3, 2021 10.24 Bn
Jul 4, 2021 10.03 Bn